Mereo BioPharma Group plc
MREO—
Mereo BioPharma Group plcMREO$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-0.05
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$500,000
Net income
$-41.88M
Net margin
-8375.6%
Gross margin
—
Dividends & financials
Mereo BioPharma Group plc (MREO) reported revenue of $500,000 and net income of $-41.88M, or $-0.05 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.